Related Experiment Video
Updated: Mar 17, 2026

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
Published on: September 3, 2016
Strain competition restricts colonization of an enteric pathogen and prevents colitis
Aaron L Hecht1, Benjamin W Casterline1, Zachary M Earley2
1Department of Microbiology, University of Chicago, Chicago, IL, USA Interdisciplinary Scientist Training Program, University of Chicago, Chicago, IL, USA.
Abstract:
The microbiota is a major source of protection against intestinal pathogens; however, the specific bacteria and underlying mechanisms involved are not well understood. As a model of this interaction, we sought to determine whether colonization of the murine host with symbiotic non-toxigenic Bacteroides fragilis could limit acquisition of pathogenic enterotoxigenic B. fragilis We observed strain-specific competition with toxigenic B. fragilis, dependent upon type VI secretion, identifying an effector-immunity pair that confers pathogen exclusion. Resistance against host acquisition of a second non-toxigenic strain was also uncovered, revealing a broader function of type VI secretion systems in determining microbiota composition. The competitive exclusion of enterotoxigenic B. fragilis by a non-toxigenic strain limited toxin exposure and protected the host against intestinal inflammatory disease. Our studies demonstrate a novel role of type VI secretion systems in colonization resistance against a pathogen. This understanding of bacterial competition may be utilized to define a molecularly targeted probiotic strategy.
More Related Videos
Related Concept Videos
Stringent Response in E. coli
Competition
Gene Regulation in Microbial Communities: Quorum Sensing
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Antibiotic Selection

